Cyclosporin drug-interaction-induced rhabdomyolysis. A report of two cases in lung transplant recipients.
In rare cases the use of cyclosporin in transplant patients can cause myopathic changes. We describe two patients, the recipients of lung transplants, who developed severe reversible rhabdomyolysis associated with cyclosporin drug-drug interaction.
Recanati Center for Medicine, Pulmonary Institute, Rabin Medical Center, Beilinson Campus, Petach-Tikva and Sackler Medical School, Tel-Aviv, Israel.
E
E
Cohen
M R
MR
Kramer
C
C
Maoz
D
D
Ben-Dayan
M
M
Garty
D016572:Cyclosporine / Q000009:adverse effects*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016040:Lung Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced*
D007166:Immunosuppressive Agents; D016572:Cyclosporine